Skip navigation

Get exclusive benefits after your first order:

-10 %
logo placeholer

DUCRAY

DUCRAY KELUAL DS GEL SPUMANT 200ML

Product from
Farmacia
1 pc
Until 01/01
RON 85.49  RON 94.99
RON 85.49 /pc

Delivery within 3 hours


You're reading an Auto-translation.

Kelual DS Foaming Gel has a gentle cleansing base for irritated skin, with redness and scales.

The patented2 active synergy of antifungal ingredients CICLOPIROX OLAMINE and PIROCTONE OLAMINE helps regulate the excess of Malassezia responsible for redness, scales, and itching, as well as pigment spots caused by pityriasis versicolor.

Benefits:

 Mattifying effect

 Controls excess sebum

 Hydrates 24h

Clinical results:

The product's efficacy and tolerability are tested under dermatological control. Visible effects on symptoms from the FIRST3 application: skin is soothed and less irritated.
Results also perceived for skin affected by pityriasis versicolor.

Clinical results after 8 days of use

Active ingredients

 

B-glycyrrhetinic Acid
Active ingredient known for its soothing properties.

Ciclopirox Olamine
Ciclopirox Olamine combined with Piroctone Olamine forms a patented synergy of active ingredients with long-lasting cleansing properties and rapid efficacy.

INCI Composition

WATER (AQUA). DISODIUM LAURETH SULFOSUCCINATE. CETEARETH-60 MYRISTYL GLYCOL. LAURYL BETAINE. DECYL GLUCOSIDE. GLYCERYL LAURATE. 1,2-HEXANEDIOL. CAPRYLYL GLYCOL. CICLOPIROX OLAMINE. CITRIC ACID. GLYCYRRHETINIC ACID. PIROCTONE OLAMINE. SODIUM CHLORIDE. TRISODIUM ETHYLENEDIAMINE DISUCCINATE

How to apply

 

  • Apply to wet skin. Can be used on both body and face.
  • Massage gently.
  • Leave on for one minute.
  • Rinse.
  • Use daily. Once or twice a day.

Recommended care routine for seborrheic dermatitis: scalp, face, and body.

Disclaimers:
1. Clinical study on 30 subjects with mild to moderate facial seborrheic dermatitis, adults/adolescents. Clinical score evaluated by investigator (scale from 0-4).
2. Patent pending.
3. Clinical study on 30 subjects with mild to moderate facial seborrheic dermatitis, adults/adolescents. Clinical score evaluated by investigator (scale from 0-4).